These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation. Ruscetti SK J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia. Jacobs-Helber SM; Roh KH; Bailey D; Dessypris EN; Ryan JJ; Chen J; Wickrema A; Barber DL; Dent P; Sawyer ST Blood; 2003 Jan; 101(2):524-31. PubMed ID: 12393629 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-induced stimulation of differentiation and proliferation in J2E cells is not mimicked by chemical induction. Busfield SJ; Klinken SP Blood; 1992 Jul; 80(2):412-9. PubMed ID: 1627799 [TBL] [Abstract][Full Text] [Related]
15. Proliferation and differentiation of erythroleukemia cell line (ELM-I-1) in response to erythropoietin and interleukin 3. Shiozaki M; Itoh K; Mori KJ Leuk Res; 1990; 14(3):287-91. PubMed ID: 2319808 [TBL] [Abstract][Full Text] [Related]
17. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. Tilbrook PA; Ingley E; Williams JH; Hibbs ML; Klinken SP EMBO J; 1997 Apr; 16(7):1610-9. PubMed ID: 9130706 [TBL] [Abstract][Full Text] [Related]
18. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence. Wong KS; Li YJ; Howard J; Ben-David Y Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829 [TBL] [Abstract][Full Text] [Related]
19. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells. Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453 [TBL] [Abstract][Full Text] [Related]
20. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]